📈 Sabrina Esufally Appointed to Hemas Holdings Board

Hemas Holdings PLC has announced the appointment of Sabrina Esufally as an Executive Director to its Board, effective 1 July 2026. • Leadership Transition: Currently serving as the Managing Director of Hemas Consumer Brands and a member of the Group Board of Management, she has held diverse leadership roles across pharmaceutical manufacturing, business development, and innovation since joining the Group in 2019. • Strategic Direction: In her role leading the consumer brands sector—a strategically vital business unit for the Group—she has driven expansion into new consumer segments and strengthened the core brand portfolio, positioning the company for growth in frontier markets. • Professional Background: Prior to Hemas, she was the Head of Legal Research at Verité Research, focusing on governance and public policy. She is an Attorney-at-Law of the Supreme Court of Sri Lanka, holding a First Class Honours degree from the University of Durham, an LL.M. from Harvard Law School, and is an alumna of Harvard Business School.